Standard
Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide. / Horowitz, M; Vilsbøll, Tina; Zdravkovic, M; Hammer, M; Madsbad, S.
I:
Diabetes, Obesity and Metabolism, Bind 10, Nr. 7, 01.07.2008, s. 593-6.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Horowitz, M
, Vilsbøll, T, Zdravkovic, M, Hammer, M
& Madsbad, S 2008, '
Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide',
Diabetes, Obesity and Metabolism, bind 10, nr. 7, s. 593-6.
https://doi.org/10.1111/j.1463-1326.2008.00861.x,
https://doi.org/10.1111/j.1463-1326.2008.00861.xAPA
Horowitz, M.
, Vilsbøll, T., Zdravkovic, M., Hammer, M.
, & Madsbad, S. (2008).
Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide.
Diabetes, Obesity and Metabolism,
10(7), 593-6.
https://doi.org/10.1111/j.1463-1326.2008.00861.x,
https://doi.org/10.1111/j.1463-1326.2008.00861.xVancouver
Author
Horowitz, M ; Vilsbøll, Tina ; Zdravkovic, M ; Hammer, M ; Madsbad, S. / Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide. I: Diabetes, Obesity and Metabolism. 2008 ; Bind 10, Nr. 7. s. 593-6.
Bibtex
@article{0aafeca004ca11deb05e000ea68e967b,
title = "Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide",
abstract = "Udgivelsesdato: 2008/7",
author = "M Horowitz and Tina Vilsb{\o}ll and M Zdravkovic and M Hammer and S Madsbad",
year = "2008",
month = jul,
day = "1",
doi = "10.1111/j.1463-1326.2008.00861.x",
language = "English",
volume = "10",
pages = "593--6",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "7",
}
RIS
TY - JOUR
T1 - Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
AU - Horowitz, M
AU - Vilsbøll, Tina
AU - Zdravkovic, M
AU - Hammer, M
AU - Madsbad, S
PY - 2008/7/1
Y1 - 2008/7/1
N2 - Udgivelsesdato: 2008/7
AB - Udgivelsesdato: 2008/7
U2 - 10.1111/j.1463-1326.2008.00861.x
DO - 10.1111/j.1463-1326.2008.00861.x
M3 - Journal article
C2 - 18435773
VL - 10
SP - 593
EP - 596
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 7
ER -
